Back to top

blockchain: Archive

Zacks Equity Research

3 Reasons Growth Investors Will Love Lattice (LSCC)

Lattice (LSCC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

LSCCPositive Net Change

Zacks Equity Research

Here is Why Growth Investors Should Buy RBC Bearings (RBC) Now

RBC Bearings (RBC) could produce exceptional returns because of its solid growth attributes.

RBCNegative Net Change

Zacks Equity Research

Fortinet (FTNT) is an Incredible Growth Stock: 3 Reasons Why

Fortinet (FTNT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

FTNTPositive Net Change

Zacks Equity Research

Looking for a Growth Stock? 3 Reasons Why First Business Financial Services (FBIZ) is a Solid Choice

First Business Financial Services (FBIZ) could produce exceptional returns because of its solid growth attributes.

FBIZPositive Net Change

Zacks Equity Research

All You Need to Know About Valneva SE Sponsored ADR (VALN) Rating Upgrade to Buy

Valneva SE Sponsored ADR (VALN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

VALNNegative Net Change

Zacks Equity Research

StoneX Group Inc. (SNEX) Upgraded to Strong Buy: Here's What You Should Know

StoneX Group Inc. (SNEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SNEXPositive Net Change

Zacks Equity Research

All You Need to Know About Outfront Media (OUT) Rating Upgrade to Strong Buy

Outfront Media (OUT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

OUTNegative Net Change

Zacks Equity Research

All You Need to Know About Consol Energy (CEIX) Rating Upgrade to Strong Buy

Consol Energy (CEIX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CEIXPositive Net Change

Zacks Equity Research

Global Partners LP (GLP) Upgraded to Buy: What Does It Mean for the Stock?

Global Partners LP (GLP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GLPPositive Net Change

Zacks Equity Research

Oracle (ORCL) Down 17.9% Since Last Earnings Report: Can It Rebound?

Oracle (ORCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ORCLNegative Net Change

Zacks Equity Research

Strength Seen in Amgen (AMGN): Can Its 5.7% Jump Turn into More Strength?

Amgen (AMGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

AMGNPositive Net Change LGNDPositive Net Change

Zacks Equity Research

Wall Street Analysts Predict a 44% Upside in Old Second Bancorp (OSBC): Here's What You Should Know

The consensus price target hints at a 43.6% upside potential for Old Second Bancorp (OSBC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

OSBCPositive Net Change

Zacks Equity Research

Wall Street Analysts Predict an 80% Upside in Noodles & Co. (NDLS): Here's What You Should Know

The consensus price target hints at a 79.6% upside potential for Noodles & Co. (NDLS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

NDLSPositive Net Change

Zacks Equity Research

Wall Street Analysts Predict a 39% Upside in Perion Network (PERI): Here's What You Should Know

The consensus price target hints at a 39.4% upside potential for Perion Network (PERI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

PERINegative Net Change

Zacks Equity Research

Wall Street Analysts See a 31% Upside in BioMarin (BMRN): Can the Stock Really Move This High?

The mean of analysts' price targets for BioMarin (BMRN) points to a 30.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

BMRNNegative Net Change

Zacks Equity Research

Wall Street Analysts See a 50% Upside in ProPetro (PUMP): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 50.2% in ProPetro (PUMP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

PUMPNegative Net Change

Zacks Equity Research

Does Ascendis Pharma AS (ASND) Have the Potential to Rally 35% as Wall Street Analysts Expect?

The consensus price target hints at a 34.6% upside potential for Ascendis Pharma AS (ASND). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ASNDPositive Net Change

Zacks Equity Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

FNBPositive Net Change

Zacks Equity Research

Why Agilent Technologies (A) is a Top Stock for the Long-Term

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

ANegative Net Change

Zacks Equity Research

Albireo Pharma (ALBO) Soars 14.4%: Is Further Upside Left in the Stock?

Albireo Pharma (ALBO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ALBOPositive Net Change MRNANegative Net Change

Zacks Equity Research

Here's How Investors Can Find Strong Finance Stocks with the Zacks ESP Screener

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

CMEPositive Net Change NLYPositive Net Change

Zacks Equity Research

Here's How Investors Can Find Strong Oils and Energy Stocks with the Zacks ESP Screener

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

SWNPositive Net Change PBFNegative Net Change

Zacks Equity Research

Here's How Investors Can Find Strong Industrial Products Stocks with the Zacks ESP Screener

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

EMRPositive Net Change

Zacks Equity Research

Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Oils and Energy

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

XOMNegative Net Change EQNRNegative Net Change

Zacks Equity Research

Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

DOCSPositive Net Change UNHNegative Net Change